LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Akcea Therapeutics

Similar companies to Akcea Therapeutics

Akcea Therapeutics Tech Stack

Akcea Therapeutics uses 8 technology products and services including Adobe Sign, RxJS, Exhibit, and more. Explore Akcea Therapeutics's tech stack below.

  • Adobe Sign
    Electronic Signatures
  • RxJS
    Javascript Frameworks
  • Exhibit
    Javascript Graphics
  • PWA
    Miscellaneous
  • PHP
    Programming Languages
  • Node.js
    Programming Languages
  • Microsoft Teams
    Team Collaboration
  • Contact Form 7
    Web Platform Extensions

Media & News

Akcea Therapeutics's Email Address Formats

Akcea Therapeutics uses at least 2 format(s):
Akcea Therapeutics Email FormatsExamplePercentage
FLast@akceatx.comJDoe@akceatx.com
100%
FLast@ionispharma.comJDoe@ionispharma.com
93%
First@ionispharma.comJohn@ionispharma.com
5%
First.Last@ionispharma.comJohn.Doe@ionispharma.com
2%

Frequently Asked Questions

Where is Akcea Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Akcea Therapeutics's main headquarters is located at 55 Cambridge Parkway Cambridge, MA 02142 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Akcea Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Akcea Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Akcea Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Akcea Therapeutics is a publicly traded company; the company's stock symbol is AKCA.

What is Akcea Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Akcea Therapeutics's official website is ionispharma.com and has social profiles on LinkedIn.

How much revenue does Akcea Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2021, Akcea Therapeutics's annual revenue reached $75M.

What is Akcea Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Akcea Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Akcea Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2021, Akcea Therapeutics has approximately 179 employees across 3 continents, including North AmericaEuropeAsia. Key team members include VP Pharmacovigilance & Drug Safety: S. Y.Head Of Global Market Access, Pricing And Reimbursement: S. H.Senior Vice President, Chief Human Resources Officer: C. P.. Explore Akcea Therapeutics's employee directory with LeadIQ.

What industry does Akcea Therapeutics belong to?

Minus sign iconPlus sign icon
Akcea Therapeutics operates in the Biotechnology Research industry.

What technology does Akcea Therapeutics use?

Minus sign iconPlus sign icon
Akcea Therapeutics's tech stack includes Adobe SignRxJSExhibitPWAPHPNode.jsMicrosoft TeamsContact Form 7.

What is Akcea Therapeutics's email format?

Minus sign iconPlus sign icon
Akcea Therapeutics's email format typically follows the pattern of . Find more Akcea Therapeutics email formats with LeadIQ.

How much funding has Akcea Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2021, Akcea Therapeutics has raised $40M in funding. .

When was Akcea Therapeutics founded?

Minus sign iconPlus sign icon
Akcea Therapeutics was founded in 2015.
Akcea Therapeutics

Akcea Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Established in early 2015, Akcea Therapeutics is a wholly owned subsidiary of Ionis Pharmaceuticals, the leader in RNA therapeutics. Akcea commercializes two medicines, and with Ionis, is advancing a mature pipeline of novel medicines discovered by Ionis and based on Ionis’ proprietary antisense technology. 

Our priority is to bring transformative medicines to patients by understanding patient and physician needs, preparing the market, creating market access, and commercializing our products on a global basis.
We are driven by the knowledge that patients depend on us.

Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For the latest job postings, please visit the Ionis LinkedIn page here: https://www.linkedin.com/company/ionis-pharmaceuticals/jobs/

Section iconCompany Overview

Headquarters
55 Cambridge Parkway Cambridge, MA 02142 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
AKCA
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $40M

    Akcea Therapeutics has raised a total of $40M of funding over 1 rounds. .

  • $50M$100M

    Akcea Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $40M

    Akcea Therapeutics has raised a total of $40M of funding over 1 rounds. .

  • $50M$100M

    Akcea Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.